Work

Severe and fatal central nervous system toxicity after fludarabine, thiotepa and melphalan conditioning for allogeneic stem cell transplantation

Year: 2026
Type: article
Study design: Observational Study
Abstract: Neurological complications (NC) are a known risk after allogeneic hematopoietic stem cell transplantation (allo-HSCT). In routine clinical care, we observed unexpected severe noninfectious central nervous system (CNS) events following conditioning with fludarabine, thiotepa and melphalan (Flu-Thio-Mel). To assess the potential association between NC and Flu-Thio-Mel conditioning, we conducted a systematic retrospective evaluation of the frequency, type, location and etiology of NC in adult patients who received αβTCR+/CD19+-depleted allo-HSCT. Only NC considered conditioningrelated, based on clinical and diagnostic findings, were included. Outcomes were compared between patients receiving Flu-Thio-Mel (N=55) and patients receiving fludarabine and busulfan (Flu-Bu; N=47) as conditioning regimen for allo-HSCT. Overall, NC were frequent in both cohorts (31% after Flu-Thio-Mel and 30% after Flu-Bu) and most often clinically mild. Peripheral neuropathy was the most common manifestation. In contrast, CNS toxicity was observed exclusively in the Flu-Thio-Mel cohort (n=7), presenting as fatal leukoencephalopathy (n=3, CTCAE grade 5), severe encephalomyelopathy (n=2, CTCAE grade 3-4), and myeloneuropathy (n=2, CTCAE grade 2). Older age, impaired renal function and higher fludarabine exposure may have increased susceptibility to Flu-Thio-Mel-associated CNS toxicity. The occurrence of severe CNS toxicity (CTCAE grade 3-5) in 9% of patients after Flu-Thio-Mel warrants caution and further evaluation of this conditioning regimen, particularly in vulnerable patients.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,157
OpenAlex ID: W7236850346
FWCI:
Cites: 31
Cited by:
Related to: 10